Overview
Financials
Revenue history
Filing timeliness
2 of 4 financial statements were filed late (the longest delay 528 days for 2022).
- 202530/03/2026
- 202401/04/2025
- 202308/10/2024
- 202224/12/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Manner of representation
To represent the company and make all declarations concerning property and non-property rights and obligations: a. in the case of a one-person management board, the sole member of the management board is authorised to act independently; b. in the case of a multi-member management board, two members of the management board acting jointly, one member of the management board jointly with a commercial proxy, or two commercial proxies jointly are authorised.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sławomir Kościakage 42 | 320 | $8,643.98 | 32% |
Joanna Lewin Kowalikage 75 | 140 | $3,781.74 | 14% |
Adrian Smędowskiage 41 | 540 | $14,586.71 | 54% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrum Innowacji i Wdrożeń Bio-Inwestsp. z o.o. | $1,262,872.91 | bio-inwest.pl | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Luna Laboratorysp. z o.o. | $61,894.23 | lunalab.pl | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Immbionicsp. z o.o. | $31,756.23 | immbionic.com.pl | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com | ||
| Medical Algorithmssp. z o.o. | $682.08 | medicalalgorithms.eu | ||
| Passio Biomaterialssp. z o.o. | $0.00 | passio.pl | ||
| Codagenesp. z o.o. | – | codagene.com | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com |
FAQ
Last updated: 2026-10-07